BASF abandons pursuit of Evonik

Key highlights
  • Evonik rejected two non-binding all-cash offers from BASF.
  • BASF’s derisked offer was €24 per share.
  • BASF said Evonik’s standalone prospects and risks did not justify a higher valuation.
  • BASF said acquisitions are optional under its Winning Ways strategy and reaffirmed disciplined capital allocation.

Acquisition effort ends

BASF has ended its efforts to acquire Evonik after Evonik rejected two non-binding all-cash offers. BASF said it had indicated willingness to consider a further moderate increase, but saw no meaningful engagement from Evonik’s Executive Board.

Valuation and capital allocation

BASF said its assessment of Evonik’s standalone prospects and associated risks did not justify a higher valuation. It concluded that pursuing the transaction at a higher price would not be in the best interests of its shareholders. BASF’s derisked offer was €24 per share.

Under its Winning Ways strategy, BASF describes acquisitions as an option, not a requirement, for strengthening and growing its core businesses. The company said ending the pursuit reaffirms its commitment to disciplined capital allocation and shareholder distributions.

Source: BASF

chemXplore Weekly

The week’s project milestones and project news from the chemical industry, free every Wednesday.

Free. One email a week. Unsubscribe any time. See our Privacy Policy.